Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
B&G Foods, Inc. (BGS) - free report >>
Minerva Neurosciences, Inc (NERV) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
B&G Foods, Inc. (BGS) - free report >>
Minerva Neurosciences, Inc (NERV) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for May 11th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 11th:
Wayfair Inc. (W - Free Report) : This company that engages in the e-commerce business has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.9% over the last 60 days.
Wayfair Inc Price and Consensus
Wayfair Inc price-consensus-chart | Wayfair Inc Quote
Wayfair’s shares gained more than 100% over the last one month compared with the S&P 500 growth 5%. The company possesses a Momentum Score of A.
Wayfair Inc Price
Wayfair Inc price | Wayfair Inc Quote
Minerva Neurosciences, Inc. (NERV - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.2% over the last 60 days.
Minerva Neurosciences Inc Price and Consensus
Minerva Neurosciences Inc price-consensus-chart | Minerva Neurosciences Inc Quote
Minerva Neurosciences’ shares gained 96.4% over the last one month. The company possesses a Momentum Score of A.
Minerva Neurosciences Inc Price
Minerva Neurosciences Inc price | Minerva Neurosciences Inc Quote
Kezar Life Sciences, Inc. (KZR - Free Report) : This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.9% over the last 60 days.
Kezar Life Sciences Inc Price and Consensus
Kezar Life Sciences Inc price-consensus-chart | Kezar Life Sciences Inc Quote
Kezar Life Sciences’ shares gained 43.1% over the last one month. The company possesses a Momentum Score of A.
Kezar Life Sciences Inc Price
Kezar Life Sciences Inc price | Kezar Life Sciences Inc Quote
B&G Foods, Inc. (BGS - Free Report) : This companythat manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
BG Foods Inc Price and Consensus
BG Foods Inc price-consensus-chart | BG Foods Inc Quote
B&G Foods’ shares gained 22.1% over the last one month. The company possesses a Momentum Score of A.
BG Foods Inc Price
BG Foods Inc price | BG Foods Inc Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>